Skip to main content
HR 3091 113th Congress House Health Administrative law and regulatory procedures Administrative remedies Advisory bodies Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug therapy Executive agency funding and structure Food and Drug Administration (FDA) Government studies and investigations Intellectual property Medical research Medical tests and diagnostic methods Medicare Prescription drugs

MODDERN Cures Act of 2013

Introduced: September 12, 2013 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 113th Congress ended
It never became law before the 113th Congress (2013–2014) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 15, 2013
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Sep 13, 2013
Referred to the Subcommittee on Health.
Sep 12, 2013
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 12, 2013
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Modernizing Our Drug & Diagnostics Evaluation and Regulatory Network Cures Act of 2013 or MODDERN Cures Act of 2013 - Requires the Secretary of Health and Human Services (HHS) to: (1) establish the Advanced Diagnostics Education Council to recommend standard terms and definitions related to innovative diagnostics for use by patients, physicians, health care providers, payers, and policy makers; and (2) publish a guide regarding such terms and definitions.

Sets forth additional factors for the Secretary to consider in determining the payment amount for new clinical diagnostic laboratory tests under gap filling procedures which are used when no comparable existing test is available.

Extends the exclusivity period for a medicine if the diagnostic test related to such drug has been determined by the Secretary to have been developed by, or with the participation of, the manufacturer or sponsor of the medicine, and use of the diagnostic tests provides for or improves: (1) the identification of a patient population for the medicine; or (2) the determination of the most appropriate treatment option for a patient population with the medicine.

Establishes a dormant therapy designation for medicine that addresses unmet medical needs. Gives such medicine 15 years of data exclusivity under which no drug can be approved by relying on the approval or licensure of the dormant therapy.

Directs the Secretary to arrange with the Institute of Medicine (or, if it declines, another appropriate entity) to study intellectual property laws and their impact on therapy and diagnostic development in order to formulate recommendations on how to facilitate the clinical evaluation and development of therapies currently available on the market for new potential indications.

What's happening now October 15, 2013

Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

 Related & companion bills 2
  • HR 2085 Related bill Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
  • HR 3116 Related bill MODDERN Cures Act of 2013
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
 Cosponsors 13
All 13 Republican 3
R
Buchanan, Vern
Florida · Oct 2, 2013
Ellison, Keith
· Sep 12, 2013
 R
Guthrie, Brett
Kentucky · Sep 12, 2013
JONES, WALTER
· Sep 12, 2013
KING, PETER
· Sep 12, 2013
Loebsack, David
· Sep 12, 2013
Long, Billy
· Sep 12, 2013
 R
McCaul, Michael T.
Texas · Sep 12, 2013
Paulsen, Erik
· Sep 12, 2013
Roskam, Peter
· Sep 12, 2013
Schwartz, Allyson
· Sep 12, 2013
TIBERI, PATRICK
· Sep 12, 2013
WALDEN, GREG
· Sep 12, 2013
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3091: MODDERN Cures Act of 2013. 113th Congress. Open America. https://openamerica.io/bill/113-HR-3091/
MLA
"H.R. 3091: MODDERN Cures Act of 2013." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-HR-3091/.
Bluebook (legal)
H.R. 3091, 113th Cong. (2026), https://openamerica.io/bill/113-HR-3091/.
Markdown link
[H.R. 3091: MODDERN Cures Act of 2013](https://openamerica.io/bill/113-HR-3091/)
Report a problem